Study of AggreGuide A-100 (ADP) Assay
NCT03111420
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
280
Enrollment
INDUSTRY
Sponsor class
Conditions
Risk Factor, Cardiovascular
Platelet Dysfunction Due to Drugs
Interventions
DRUG:
P2Y12 inhibitor
DEVICE:
Platelet function test
Sponsor
Aggredyne, Inc.